Skye Bioscience, Inc. Quarterly Common Stock, Shares Authorized from Q3 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Skye Bioscience, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2012 to Q2 2024.
  • Skye Bioscience, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 100M shares, a 98% decline year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 100M -4.9B -98% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 100M -4.9B -98% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 100M +80M +400% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 20M -4.98B -99.6% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 5B 0 0% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 5B 0 0% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 20M -4.98B -99.6% Dec 31, 2022 10-K 2024-03-22
Q3 2022 5B 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 5B 0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 5B 0 0% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 5B +4.5B +900% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 5B +4.5B +900% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 5B +4.5B +900% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 5B +4.5B +900% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 500M 0 0% Dec 31, 2020 10-K 2022-03-28
Q3 2020 500M 0 0% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 500M 0 0% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 500M 0 0% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 500M 0 0% Dec 31, 2019 10-K 2021-03-02
Q3 2019 500M +264M +112% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 500M +264M +112% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 500M +264M +112% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 500M 0 0% Dec 31, 2018 10-K 2020-03-23
Q3 2018 236M 0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 236M 0 0% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 236M 0 0% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 500M +264M +112% Dec 31, 2017 10-K 2019-03-14
Q3 2017 236M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 236M 0 0% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 236M 0 0% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 236M 0 0% Dec 31, 2016 10-K 2018-03-19
Q3 2016 236M 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 236M 0 0% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 236M 0 0% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 236M 0 0% Dec 31, 2015 10-K 2017-03-10
Q3 2015 236M +136M +136% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 236M +136M +136% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 236M +136M +136% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 236M 0 0% Dec 31, 2014 10-K 2016-03-21
Q3 2014 100M 0 0% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 100M 0 0% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 100M 0 0% Apr 30, 2014 10-Q 2014-06-05
Q4 2013 236M Dec 31, 2013 10-K 2015-03-27
Q3 2013 100M 0 0% Oct 31, 2013 10-Q 2014-09-15
Q2 2013 100M Jul 31, 2013 10-Q 2013-09-16
Q1 2013 100M Apr 30, 2013 10-Q 2013-06-27
Q3 2012 100M Oct 31, 2012 10-K 2014-01-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.